دورية أكاديمية
A clinical case of early multifocal atherosclerosis complicated by acute coronary syndrome in a young man with ulcerative colitis ; Клинический случай раннего мультифокального атеросклероза, осложненного острым коронарным синдромом, у молодого мужчины с язвенным колитом
| العنوان: | A clinical case of early multifocal atherosclerosis complicated by acute coronary syndrome in a young man with ulcerative colitis ; Клинический случай раннего мультифокального атеросклероза, осложненного острым коронарным синдромом, у молодого мужчины с язвенным колитом |
|---|---|
| المؤلفون: | L. V. Tarasova, N. Yu. Kucherova, Yu. V. Tsyganova, Л. В. Тарасова, Н. Ю. Кучерова, Ю. В. Цыганова |
| المصدر: | Meditsinskiy sovet = Medical Council; № 18 (2023); 151-158 ; Медицинский Совет; № 18 (2023); 151-158 ; 2658-5790 ; 2079-701X |
| بيانات النشر: | REMEDIUM GROUP Ltd. |
| سنة النشر: | 2023 |
| المجموعة: | Medical Council (E-Journal) / Медицинский Совет |
| مصطلحات موضوعية: | атерогенез, extraintestinal manifestations, cardiovascular complications, ischaemic heart disease, Crohn’s disease, еndothelium dysfunction, atherogenesis, внекишечные проявления, сердечно-сосудистые осложнения, ишемическая болезнь сердца, болезнь Крона, системное воспаление, эндотелиальная дисфункция |
| الوصف: | Inflammatory bowel disease (IBD) is a chronic, relapsing, systemic and immune-mediated conditiondis that frequently involve extraintestinal manifestations. Latest studies showed increased risk of cardiovascular complications, which is the main cause of death in developed countries, in chronic inflammatory disorders, especially during IBD relapses. IBD patients are at increased risk of conditions such as early atherosclerosis, ischaemic heart disease, myocardial infarction, stroke, venous thrombosis, heart failure, аtrial fibrillation. Hypotheses for the mechanism underlying the association of IBD and atherosclerotic cardiovascular diseases include adverse effects of both the IBD itself (chronic inflammation, еndothelium dysfunction, dyslipidemia, thrombocytosis, gut microbiome dysfunction) and its treatment. The predominant role in atherogenesis is currently assigned to disruption of the endothelium. Endothelium plays an important role in physiologic regulation of vascular tone, cell adhesion, migration and resistance to thrombosis. Also, its dysfunction is associated with increased risk of atherosclerosis development. Early multifocal atherosclerosis is a serious complication of ulcerative colitis and can occur in young people without traditional cardiovascular risk factors. Untimely diagnosis, lack of pathogenetic treatment, correction of basic anti-inflammatory therapy and comprehensive consideration of a problem of high cardiovascular risk can lead to acute myocardial infarction and stroke and disability of a patient of working age. The authors present a case report of multifocal atherosclerosis complicated by acute coronary syndrome in a young man with ulcerative colitis, who required a radical revision of the therapy. ; Воспалительные заболевания кишечника (ВЗК), к которым относится язвенный колит и болезнь Крона, – это хронические рецидивирующие системные и иммуноопосредованные состояния, часто сопровождающиеся внекишечными проявлениями. Последние исследования показали повышенный риск сердечно-сосудистых ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Russian |
| العلاقة: | https://www.med-sovet.pro/jour/article/view/7866/6987Test; Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2018;24(4):916–923. https://doi.org/10.1093/ibd/izx089Test.; Lazou A, Ikonomidis I, Bartekova M, Benedek T, Makavos G, Palioura D et al. Chronic inflammatory diseases, myocardial function and cardioprotection. Br J Pharmacol. 2020;177(23):5357–5374. https://doi.org/10.1111/bph.14975Test.; Zanoli L, Inserra G, Castellino P. Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox. Trends Cardiovasc Med. 2015;25(8):705–706. https://doi.org/10.1016/j.tcm.2015.04.001Test.; Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients. 2020;12(5):1434. https://doi.org/10.3390/nu12051434Test.; Лищинская АА, Князев ОВ, Каграманова АВ, Дудина ГА, Сабельникова ЕА, Ли ИА и др. Частота и факторы риска тромбоэмболических осложнений у пациентов с воспалительными заболеваниями кишечника. Терапевтический архив. 2022;94(2):172–179. https://doi.org/10.26442/00403660.2022.02.201367Test.; Gala D, Newsome T, Roberson N, Lee SM, Thekkanal M, Shah M et al. Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview. Diseases. 2022;10(4):73. https://doi.org/10.3390/diseases10040073Test.; Faye AS, Lee KE, Dodson J, Chodosh J, Hudesman D, Remzi F et al. Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Aliment Pharmacol Ther. 2022;56(7):1157–1167. https://doi.org/10.1111/apt.17162Test.; Qu C, Cao J, Liu K, Tan B, Zhu C, Li K, Qu L. Crohn’s Disease Complicated With Extensive Thrombosis of Limbs and Mesenteric Arteries: A Case Report and Literature Review. Ann Vasc Surg. 2019;58:382.e15–382.e19. https://doi.org/10.1016/j.avsg.2018.12.079Test.; Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death – a Danish nationwide cohort study. PLoS ONE. 2013;8(2):e56944. https://doi.org/10.1371/journal.pone.0056944Test.; Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018;16(10):1607–1615.e1. https://doi.org/10.1016/j.cgh.2018.04.031Test.; Pepe M, Cecere A, D’Alessandro P, Fumarola F, Ciccone MM, Marchese A et al. Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk. Clin Exp Med. 2018;18(4):481–485. https://doi.org/10.1007/s10238-018-0522-5Test.; Panico C, Condorelli G. Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. Clin Rev Allergy Immunol. 2018;55(3):254–270. https://doi.org/10.1007/s12016-017-8624-5Test.; Choi YJ, Choi EK, Han KD, Park J, Moon I, Lee E et al. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol. 2019;25(22):2788–2798. https://doi.org/10.3748/wjg.v25.i22.2788Test.; Zuin M, Zuliani G, Rigatelli G, Favero GD, Roncon L. Atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis. Eur J Intern Med. 2020;76:120–122. https://doi.org/10.1016/j.ejim.2020.02.029Test.; Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol. 2020;26(12):1231–1241. https://doi.org/10.3748/wjg.v26.i12.1231Test.; Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease? Trends Cardiovasc Med. 2020;30(8):463–469. https://doi.org/10.1016/j.tcm.2019.10.001Test.; Gravina AG, Dallio M, Masarone M, Rosato V, Aglitti A, Persico M et al. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets. Oxid Med Cell Longev. 2018:2568569. https://doi.org/10.1155/2018/2568569Test.; Dowsett L, Higgins E, Alanazi S, Alshuwayer NA, Leiper FC, Leiper J. ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis. J Clin Med. 2020;9(9):3026. https://doi.org/10.3390/jcm9093026Test.; Бабаева ГК, Бабаев ЗО. Частота выявления некоторых маркеров эндотелиальной дисфункции у больных с воспалительными заболеваниями кишечника. Терапевтический архив. 2018;90(4):12–16. Режим доступа: https://ter-arkhiv.ru/0040-3660/article/view/32439Test.; Магрук МА, Мосикян АА, Бабенко АЮ. Биомаркеры, ассоциированные с атерогенезом: актуальный статус и перспективные направления. Российский кардиологический журнал. 2019;(12):148–152. https://doi.org/10.15829/1560-4071-2019-12-148-152Test.; Миронова ОЮ, Исайкина МА, Хасиева СА. Атеросклероз и сердечно-сосудистый риск у пациентов с воспалительными заболеваниями кишечника. Терапевтический архив. 2021;93(12):1533–1538. https://doi.org/10.26442/00403660.2021.12.201225Test.; Гриневич ВБ, Радченко ВГ. Микробиота кишечника и метаболический синдром. Экспериментальная и клиническая гастроэнтерология. 2020;183(11):11–19. https://doi.org/10.31146/1682-8658-ecg-183-11-11-19Test.; Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z et al. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. Biomolecules. 2019;9(12):780. https://doi.org/10.3390/biom9120780Test.; Mitchell NE, Harrison N, Junga Z, Singla M. Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018;24(11):2322–2326. https://doi.org/10.1093/ibd/izy157Test.; Grillo TG, Silveira CFDSMP, Quaglio AEV, Dutra RM, Baima JP, Bazan SGZ, Sassaki LY. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature. World J Cardiol. 2023;15(5):217–228. https://doi.org/10.4330/wjc.v15.i5.217Test.; Konstantinou CS, Korantzopoulos P, Fousekis FS, Katsanos KH. Inflammatory bowel disease and atrial fibrillation: a contemporary overview. Eur J Gastroenterol Hepatol. 2023;35(7):695–701. https://doi.org/10.1097/MEG.0000000000002562Test.; Gawałko M, Balsam P, Lodziński P, Grabowski M, Krzowski B, Opolski G, Kosiuk J. Cardiac Arrhythmias in Autoimmune Diseases. Circ J. 2020;84(5):685–694. https://doi.org/10.1253/circj.CJ-19-0705Test.; Mubasher M, Syed T, Hanafi A, Yu Z, Yusuf I, Abdullah AS et al. An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database. Clin Med Insights Cardiol. 2020;14:1179546820955179. https://doi.org/10.1177/1179546820955179Test.; Cheng CY, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP. Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev. 2022;21(4):103037. https://doi.org/10.1016/j.autrev.2022.103037Test.; Giordani AS, Candelora A, Fiacca M, Cheng C, Barberio B, Baritussio A et al. Myocarditis and inflammatory bowel diseases: A single-center experience and a systematic literature review. Int J Cardiol. 2023;376:165–171. https://doi.org/10.1016/j.ijcard.2023.01.071Test.; Patel RS, Rohit Reddy S, Llukmani A, Hashim A, Haddad DR, Patel DS et al. Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management of Pericarditis. Cureus. 2021;13(3):e14010. https://doi.org/10.7759/cureus.14010Test.; Taha ME, Abdalla A, Al-Khafaji J, Malik S. Mesalamine-Induced Myopericarditis: A Case Report and Literature Review. Cardiol Res. 2019;10(1):59–62. https://doi.org/10.14740/cr820Test.; Shah-Khan SM, Shah-Khan SM, Alqahtani F, Kupec JT. Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease. Cureus. 2020;12(2):e6919. https://doi.org/10.7759/cureus.6919Test.; Garcia-Pena A, Ibarrola J, Navarro A, Sadaba A, Tiraplegui C, Garaikoetxea M et al. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. Int J Mol Sci. 2021;22(5):2310. https://doi.org/10.3390/ijms22052310Test.; De Almeida Martins C, Caon AER, Facanali CBG, Sobrado CW, Nahas SC, Pereira RMR et al. Coexistence of Takayasu’s Arteritis in Patients with Inflammatory Bowel Diseases. Gastroenterol Res Pract. 2021:8831867. https://doi.org/10.1155/2021/8831867Test.; Weissman S, Sinh P, Mehta TI, Thaker RK, Derman A, Heiberger C et al. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020;11(5):104–113. https://doi.org/10.4291/wjgp.v11.i5.104Test.; Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis. 2023;29(4):531–538. https://doi.org/10.1093/ibd/izac100Test.; Colombel JF, Sands BE, Gasink C, Yeager B, Adedokun OJ, Izanec J et al. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease. Clin Gastroenterol Hepatol. 2023:S1542-3565(23)00499-8. https://doi.org/10.1016/j.cgh.2023.06.014Test.; Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–1565. https://doi.org/10.1056/NEJMoa021993Test.; Casas-Deza D, Lamuela-Calvo LJ, Gomollón F, Arbonés-Mainar JM, Caballol B, Gisbert JP et al. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry. J Crohns Colitis. 2023;17(1):83–91. https://doi.org/10.1093/ecco-jcc/jjac108Test.; Lambin T, Faye AS, Colombel JF. Inflammatory Bowel Disease Therapy and Venous Thromboembolism. Curr Treat Options Gastroenterol. 2020;18(3):462–475. https://doi.org/10.1007/s11938-020-00304-zTest.; https://www.med-sovet.pro/jour/article/view/7866Test |
| DOI: | 10.21518/ms2023-306 |
| الإتاحة: | https://doi.org/10.21518/ms2023-306Test https://doi.org/10.1093/ibd/izx089Test https://doi.org/10.1111/bph.14975Test https://doi.org/10.1016/j.tcm.2015.04.001Test https://doi.org/10.3390/nu12051434Test https://doi.org/10.26442/00403660.2022.02.201367Test https://doi.org/10.3390/diseases10040073Test https://doi.org/10.1111/apt.17162Test https://doi.org/10.1016/j.avsg.2018.12.079Test https://doi.org/10.1371/journal.pone.0056944Test |
| حقوق: | Authors publishing their articles in this journal shall agree to the following:Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY- NC-ND), which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the institute’s repository, publication in a book), with reference to its original publication in this journal.Authors have the right to post work on the Internet (for example, in the institute’s repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License (CC BY- NC-ND), которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию.Авторы имеют право размещать работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу. (См. The Effect of Open Access). |
| رقم الانضمام: | edsbas.9D4FDF1D |
| قاعدة البيانات: | BASE |
| DOI: | 10.21518/ms2023-306 |
|---|